Primaxin

Land: New Zealand

Språk: engelsk

Kilde: Medsafe (Medicines Safety Authority)

Aktiv ingrediens:

Cilastatin sodium 571mg equivalent to to 500 mg cilastatin acid. Includes 4.6% overage.; Imipenem monohydrate 560mg equivalent to to 500 mg imipenem. Includes 4.6% overage.

Tilgjengelig fra:

Merck Sharp & Dohme (New Zealand) Limited

INN (International Name):

Cilastatin sodium 571 mg (Equiv. to 500 mg cilastatin acid. Includes 4.6% overage.)

Legemiddelform:

Powder for injection

Sammensetning:

Active: Cilastatin sodium 571mg equivalent to to 500 mg cilastatin acid. Includes 4.6% overage. Imipenem monohydrate 560mg equivalent to to 500 mg imipenem. Includes 4.6% overage. Excipient: Sodium bicarbonate

Enheter i pakken:

Ampoule, glass, 5x13ml (Monovial), 5 dose units

Klasse:

Prescription

Resept typen:

Prescription

Produsert av:

Merck Sharp & Dohme Corp

Produkt oppsummering:

Package - Contents - Shelf Life: Ampoule, glass, 5x13ml (Monovial) - 5 dose units - 24 months from date of manufacture stored at or below 25°C 4 hours reconstituted stored at or below 25°C 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze)

Autorisasjon dato:

1996-03-20